These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

736 related articles for article (PubMed ID: 26055355)

  • 21. Action of hypoxia-inducible factor in liver and kidney from mice with Pax8-rtTA-based deletion of von Hippel-Lindau protein.
    Mathia S; Paliege A; Koesters R; Peters H; Neumayer HH; Bachmann S; Rosenberger C
    Acta Physiol (Oxf); 2013 Mar; 207(3):565-76. PubMed ID: 23384425
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Not Available].
    Hermine O; Maciel T; Moura I
    Nephrol Ther; 2017 Jun; 13(6S):6S7-6S10. PubMed ID: 29463398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute postnatal ablation of Hif-2alpha results in anemia.
    Gruber M; Hu CJ; Johnson RS; Brown EJ; Keith B; Simon MC
    Proc Natl Acad Sci U S A; 2007 Feb; 104(7):2301-6. PubMed ID: 17284606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pathogenesis and treatment of anemia in chronic kidney disease].
    Nangaku M
    Rinsho Ketsueki; 2017; 58(10):1860-1863. PubMed ID: 28978825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resistance to Recombinant Human Erythropoietin Therapy in a Rat Model of Chronic Kidney Disease Associated Anemia.
    Garrido P; Ribeiro S; Fernandes J; Vala H; Rocha-Pereira P; Bronze-da-Rocha E; Belo L; Costa E; Santos-Silva A; Reis F
    Int J Mol Sci; 2015 Dec; 17(1):. PubMed ID: 26712750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal anemia: from incurable to curable.
    Sato Y; Yanagita M
    Am J Physiol Renal Physiol; 2013 Nov; 305(9):F1239-48. PubMed ID: 23884144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generation of renal Epo-producing cell lines by conditional gene tagging reveals rapid HIF-2 driven Epo kinetics, cell autonomous feedback regulation, and a telocyte phenotype.
    Imeri F; Nolan KA; Bapst AM; Santambrogio S; Abreu-Rodríguez I; Spielmann P; Pfundstein S; Libertini S; Crowther L; Orlando IMC; Dahl SL; Keodara A; Kuo W; Kurtcuoglu V; Scholz CC; Qi W; Hummler E; Hoogewijs D; Wenger RH
    Kidney Int; 2019 Feb; 95(2):375-387. PubMed ID: 30502050
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypoxia, HIF, and Associated Signaling Networks in Chronic Kidney Disease.
    Liu J; Wei Q; Guo C; Dong G; Liu Y; Tang C; Dong Z
    Int J Mol Sci; 2017 Apr; 18(5):. PubMed ID: 28468297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of the hypoxia inducible factors HIF in iron metabolism.
    Peyssonnaux C; Nizet V; Johnson RS
    Cell Cycle; 2008 Jan; 7(1):28-32. PubMed ID: 18212530
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New Strategies for Anaemia Management in Chronic Kidney Disease.
    Locatelli F; Del Vecchio L
    Contrib Nephrol; 2017; 189():184-188. PubMed ID: 27951566
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypoxia and hypoxia-inducible factor in renal disease.
    Nangaku M; Inagi R; Miyata T; Fujita T
    Nephron Exp Nephrol; 2008; 110(1):e1-7. PubMed ID: 18667839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypoxia-Inducible Factor Stabilizers: a New Avenue for Reducing BP While Helping Hemoglobin?
    Yousaf F; Spinowitz B
    Curr Hypertens Rep; 2016 Mar; 18(3):23. PubMed ID: 26894597
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Current insights into the role of HIF-PHD axis in renal anemia].
    Cao JY; Liu BC
    Sheng Li Xue Bao; 2018 Dec; 70(6):623-629. PubMed ID: 30560271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal Cell Protection of Erythropoietin beyond Correcting The Anemia in Chronic Kidney Disease Patients.
    Nasri H
    Cell J; 2014; 15(4):378-80. PubMed ID: 24381864
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathophysiology of anemia in chronic kidney diseases: A review.
    Zadrazil J; Horak P
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Jun; 159(2):197-202. PubMed ID: 24401900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Role of inflammation on renal anaemia].
    Icardi A; Sacco P; Tarroni A; Cappelletti L; Cozzolino M
    G Ital Nefrol; 2013; 30(6):. PubMed ID: 24402666
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Erythropoiesis and chronic kidney disease-related anemia: From physiology to new therapeutic advancements.
    Cernaro V; Coppolino G; Visconti L; Rivoli L; Lacquaniti A; Santoro D; Buemi A; Loddo S; Buemi M
    Med Res Rev; 2019 Mar; 39(2):427-460. PubMed ID: 30084153
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emerging drugs for the treatment of kidney disease-induced anemia.
    Malyszko J; Malyszko JS
    Expert Opin Emerg Drugs; 2016 Sep; 21(3):315-30. PubMed ID: 27537859
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathogenesis of renal anemia.
    Nangaku M; Eckardt KU
    Semin Nephrol; 2006 Jul; 26(4):261-8. PubMed ID: 16949463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New expectations in the treatment of anemia in chronic kidney disease.
    López-Gómez JM; Abad S; Vega A
    Nefrologia; 2016; 36(3):232-6. PubMed ID: 27137103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.